MAPT and Alzheimer disease: Several studies in Alzheimer’s disease show that CK2 phosphorylates SET on Ser9, in the nuclear localization signal, which is key for SET cytoplasmic localization and inhibition of PP2A, leading to tau hyperphosphorylation30,31,48.